Using antioxidant-rich media to improve embryo quality in IVF
Official title: Antioxidants-enriched Single-step vs Global Total Single-step Embryo Culture Media: Effect on Blastocyst Euploidy Rates.
Run by ART Fertility Clinics LLC · NCT06261671 · Data updated 2026-11-12
This study is testing if using a special culture solution with antioxidants can help improve the quality of embryos for people undergoing IVF.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 43 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | ART Fertility Clinics LLC Academic / other |
| Locations | 1 site (Abu Dhabi, Abu Dhabi Emirate) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | February 21, 2025 |
| Trial ID | NCT06261671 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18-43 undergoing IVF with sufficient oocytes for intracytoplasmic sperm injection (ICSI).
✕Probably not a fit
Patients undergoing preimplantation genetic testing for monogenic disorders (PGT-M) or those using testicular sperm will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effect of antioxidant-enriched culture media on the euploidy rates of embryos during in vitro fertilization (IVF). It aims to address the negative impact of reactive oxidative species (ROS) on embryo development by utilizing a culture medium that contains higher concentrations of antioxidants. The trial will involve a randomized approach using sibling oocytes from patients undergoing assisted reproductive technology cycles. The primary goal is to determine if this improved culture condition can enhance the quality of embryos suitable for implantation.
Why it matters
Potential benefit: If successful, this approach could lead to higher rates of viable embryos and improved outcomes for patients undergoing IVF.
How similar studies have gone: While few human IVF studies have explored this approach, animal models have shown promising results, indicating potential for success in human applications.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing assisted reproductive technology cycles when ICSI is indicated. * Patients when Iin vitto fertilization (IVF) is also performed will be included as far as there are enough oocytes for ICSI randomization. However, IVF oocytes will not be used for the study. * Maternal age 18-43 years old. * PGT-A cycles with only trophectoderm biopsies on day 5/6/7. * Patients with more than 6 COCs expected for ICSI. * Body mass index \<35. * Fresh and frozen ejaculated sperm. Exclusion Criteria: * PGT-M cycles * Fresh and frozen testicular sperm.
Where it's running
-
ART Fertility Clinics LLC
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates Recruiting
Study contacts
- Study coordinator: Daniela Nogueira
- Email: daniela.nogueira@artfertilityclinics.com
- Phone: +971504374961
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ovarian PRP injections to try to improve embryo quality
This study tries ovarian platelet-rich plasma (PRP) injections to see if they improve embryo development for people doing IVF.
-
AI-assisted embryo selection on day 5 in IVF for infertility
This trial tests whether an AI-based embryo selection tool can help pick the best embryo for transfer on day 5 in IVF/ICSI to improve pregnancy chances for people with infertility.
-
Preserving sperm quality with aging through cryopreservation
This study tests whether freezing and thawing sperm can help keep younger-like DNA and molecular traits in men as they age.
-
Unstimulated Egg Retrieval with CAPA-IVM and Euploid Embryo Transfer
This study tests whether eggs can be collected without ovarian stimulation, matured in the lab, and used to create a single euploid embryo for transfer in infertility patients.
-
Ultra-Long GnRH-a Pretreatment Before Frozen Embryo Transfer for Deep Infiltrating Endometriosis
In people under 40 with deep infiltrating endometriosis and infertility, the study tests whether two injections of a GnRH agonist before hormone support improve pregnancy outcomes in their first frozen-thawed embryo transfer.
-
Endometrial Waves and Pregnancy in FET Cycles with Hormone Therapy
This study tests whether patterns of uterine contractions during hormone-prepared frozen embryo transfer affect pregnancy outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.